PROSTATE DRUGS: Approval soon for drug to prevent bone fracture in cancer patients

MAY 14: MEMPHIS DAILY NEWS:  Memphis company GTx expects to receive approval from the US Food and Drug Administration on Octopber 30 to begin selling a drug to prevent bone fractures in men undergoing hormone therapy to treat bone cancer. The company also has other drugs in the pipeline related to the prevention and treatment of prostate cancer and to build body mass in people with cancer-induced muscle loss. READ MORE>